These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35652692)

  • 1. HbA1c Variability as an Independent Risk Factor for Microvascular Complications in Type 1 Diabetes.
    Mao Y; Zhong W
    J Diabetes Sci Technol; 2024 Mar; 18(2):380-388. PubMed ID: 35652692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HbA1c variability and long-term glycemic control are linked to diabetic retinopathy and glomerular filtration rate in patients with type 1 diabetes and multiethnic background.
    Rosa LCGFD; Zajdenverg L; Souto DL; Dantas JR; Pinto MVR; Salles GFDCM; Rodacki M
    J Diabetes Complications; 2019 Sep; 33(9):610-615. PubMed ID: 31227288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intensive glycemic control on microvascular outcomes in type 2 diabetes mellitus are modified by long-term HbA
    Wang JM; Miao MY; Jia YP; Wang XW; Wu XB; Wan ZX; Zheng Y; Qin LQ; Li FR; Chen GC
    Diabetes Res Clin Pract; 2024 Feb; 208():111100. PubMed ID: 38246509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycated hemoglobin variability and microvascular complications in patients with type 1 diabetes mellitus.
    Er E; Ata A; Evin F; Altınok YA; Demir G; Özen S; Darcan Ş; Gökşen D
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1533-1537. PubMed ID: 33581707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus.
    Bharucha AE; Batey-Schaefer B; Cleary PA; Murray JA; Cowie C; Lorenzi G; Driscoll M; Harth J; Larkin M; Christofi M; Bayless M; Wimmergren N; Herman W; Whitehouse F; Jones K; Kruger D; Martin C; Ziegler G; Zinsmeister AR; Nathan DM;
    Gastroenterology; 2015 Aug; 149(2):330-9. PubMed ID: 25980755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Observational Study of the Equivalence of Age and Duration of Diabetes to Glycemic Control Relative to the Risk of Complications in the Combined Cohorts of the DCCT/EDIC Study.
    Bebu I; Braffett BH; Schade D; Sivitz W; Malone JI; Pop-Busui R; Lorenzi GM; Lee P; Trapani VR; Wallia A; Herman WH; Lachin JM;
    Diabetes Care; 2020 Oct; 43(10):2478-2484. PubMed ID: 32788280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.
    Monnier VM; Sell DR; Gao X; Genuth SM; Lachin JM; Bebu I;
    BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35058313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
    Lenherr SM; Clemens JQ; Braffett BH; Dunn RL; Cleary PA; Kim C; Herman WH; Hotaling JM; Jacobson AM; Brown JS; Wessells H; Sarma AV;
    Diabet Med; 2016 Nov; 33(11):1528-1535. PubMed ID: 27028025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabetes Care; 2009 Oct; 32(10):1901-3. PubMed ID: 19549736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing type 2 diabetes using Hemoglobin A1c: a systematic review and meta-analysis of the diagnostic cutpoint based on microvascular complications.
    Butler AE; English E; Kilpatrick ES; Östlundh L; Chemaitelly HS; Abu-Raddad LJ; Alberti KGMM; Atkin SL; John WG
    Acta Diabetol; 2021 Mar; 58(3):279-300. PubMed ID: 33141338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early risk stratification in pediatric type 1 diabetes.
    Broe R
    Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term poor glycemic control and retinal microvascular changes in pediatric Type 1 Diabetes patients in Singapore: a pilot study.
    Li LJ; Lamoureux E; Wong TY; Lek N
    BMC Ophthalmol; 2017 Jun; 17(1):60. PubMed ID: 28615013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
    Lachin JM; Bebu I; Bergenstal RM; Pop-Busui R; Service FJ; Zinman B; Nathan DM;
    Diabetes Care; 2017 Jun; 40(6):777-783. PubMed ID: 28404658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.
    Orchard TJ; Lyons TJ; Cleary PA; Braffett BH; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
    Diabetes Care; 2013 Oct; 36(10):3146-53. PubMed ID: 23813757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.
    Kilpatrick ES; Rigby AS; Atkin SL
    Diabetes Care; 2008 Nov; 31(11):2198-202. PubMed ID: 18650371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study.
    Fährmann ER; Adkins L; Loader CJ; Han H; Rice KM; Denvir J; Driscoll HK
    Diabetes Res Clin Pract; 2015 Feb; 107(2):280-9. PubMed ID: 25467622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.